Stockholm, December 3, 2015 — Nasdaq (Nasdaq: NDAQ) announced that Camurus AB (short name: CAMX), a mid cap company within the health care sector, has started trading of its shares on the main market of Nasdaq Stockholm. Camurus is the 89 th company to list at Nasdaq’s Nordic markets* in 2015.
Camurus is a Swedish research-based pharmaceutical company that develops and commercialises new and innovative medicines for treatment of serious and chronic conditions. The company applies its scientific expertise, development resources, and proprietary FluidCrystal ® technologies, including long-acting depot injections, to develop products that have the potential to provide meaningful improvements in the treatment and quality of life of patients. Camurus’ clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with global and specialty pharmaceutical companies. For more information, please visit www.camurus.com .
“Camurus listing on Nasdaq Stockholm represents an important company milestone that will enhance our growth and ability to execute on the strategy of bringing important new medicines to patients suffering from serious and chronic conditions,” said Fredrik Tiberg, CEO of Camurus.
“We are delighted to welcome Camurus to the Nasdaq Stockholm main market, where it will make a compelling addition to our health care sector” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “We continue to see a strong inflow of companies using the public markets to raise capital, and today’s listing underlines that trend.”
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,600 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit nasdaq.com/ambition or business.nasdaq.com .
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
| Media Relations Contact: Christina Malmberg Hägerstrand +46 8 405 65 83 christina.hagerstrand@nasdaq.com |
